Symbiotec Pharmalab Ltd.

NSE: SYMBIOTEC | BSE: 544889 | ISIN: INE899I01028 | Industry: Pharmaceuticals
|
1078.2500 1.40 (0.13%)
NSE Sep 04, 2026 15:31 PM
Volume: 1.5M
 

1078.25
0.13%
ICICI Direct
biotechnology company with capabilities across three platforms- organic chemistry, biotechnology and complex injectables. It has global leadership position in corticosteroid (man-made drugs that copy natural cortisol) and steroidal-hormone active pharmaceutical ingredients, and it manufactures these products using...
Deven Choksey released a IPO Subscribe report for Symbiotec Pharmalab Ltd. on 24 Aug, 2026.
More from Symbiotec Pharmalab Ltd.
Recommended